Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
The following map members from SNOMED CT to the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (© World Health organisation 1994) 2016 Version are published (or will be published) in the SNOMED CT International Edition. These maps use ICD-10 codes identified in the WHO's Emergency use ICD codes for COVID-19 disease outbreak update 1.
1119302008
Acute disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION
Footnotes
1
20210131
138389411000119105
Acute bronchitis caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION
20210131
870590002
Acute hypoxemic respiratory failure due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131
870589006
Acute kidney injury due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131
674814021000119106
Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131
189486241000119100
Asymptomatic Severe acute respiratory syndrome coronavirus 2 infection (finding)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131
119731000146105
Cardiomyopathy due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131
1119304009
Chronic post-COVID-19 syndrome (disorder)
U09.9
Post COVID-19 condition, unspecified
20210131
119741000146102
Conjunctivitis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131
840539006
Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION
20210131
119981000146107
Dyspnea caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131
1240561000000108
Encephalopathy due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131
840546002
Exposure to Severe acute respiratory syndrome coronavirus 2 (event)
Z20.8
Contact with and exposure to other communicable disease
20200309
119751000146104
Fever caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131
1240541000000107
Infection of upper respiratory tract caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131
880529761000119102
Lower respiratory infection caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131
866151004
Lymphocytopenia due to Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131
1240531000000103
Myocarditis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131
897036007
Occupational exposure to Severe acute respiratory syndrome coronavirus 2 (event)
Z20.8
Contact with and exposure to other communicable disease
20210131
1240521000000100
Otitis media due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131
882784691000119100
Pneumonia caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131
1119303003
Post-acute COVID-19 (disorder)
U09.9
Post COVID-19 condition, unspecified
20210131
870591003
Rhabdomyolysis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131
870588003
Sepsis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131
1240581000000104
Severe acute respiratory syndrome coronavirus 2 detected (finding)
U07.1
COVID-19, virus identified
20200731
866152006
Thrombocytopenia due to Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131
1017214008
Viremia caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
U07.1
COVID-19, virus identified
MAPPED FOLLOWING WHO GUIDANCE
20210131

Information about the healthcare providers and facilities involved with the investigation, treatment, and care of patients with suspected or confirmed COVID-19 are usually recorded in electronic health records. The monitoring of medical equipment availability at healthcare facilities, such as Personal Protective Equipment (PPE) and respiratory devices, is also of utmost importance during the COVID-19 pandemic. Relevant details, which can be recorded using SNOMED CT include:
Healthcare profession
Site of care
Health management finding
Personal protective equipment
These data elements are described below, with example SNOMED CT subsets for each.
The healthcare profession is the occupation or qualification of the healthcare provider who is involved in the investigation, treatment, care or education of the patient - for example or .
CV19-PFD-HealthcareProfession Intensional Definition : <
The site of care refers to the location of the specific investigation, treatment or care setting - for example , , or .
CV19-PFD- SiteOfCare Intensional Definition : < OR << OR << OR << OR << OR <<
2.1.3 Health Management Finding
Health management finding includes concepts that describe the circumstances which affect whether the planned patient outcomes are attained, that different areas within a health organization are running appropriately, that tasks are correctly defined and assessed and that resources are used efficiently. -for example , or .
CV19-PFD- HealthManagementFinding Intensional Definition : <
Personal protective equipment is protective clothing, or other garments or equipment designed to protect the wearer's body from injury or infection - for example and
CV19-PFD- PersonalProtectiveEquipment Intensional Definition : << OR << OR << OR << OR << OR << OR << OR <<
The collection of coded COVID-19 related data can be critical for frontline service delivery, pandemic surveillance, and retrospective data analysis.
The following table lists a collection of data elements for which SNOMED CT can be used to capture COVID-19 related data.
|--- Provider and facility details([section 2.1](https://confluence.ihtsdotools.org/display/WIPCV19/2.1+Provider+and+Facility+Details?src=sidebar))|
Healthcare profession
Site of care
Health management finding
Personal protective equipment
Patient demographics
Biological sex
Gender identity
Marital or partnership status
Nationality
Clinical assessment
Symptoms
Severity
Clinical measurements
Clinical examination findings
Tests and Investigations
Specimen
Laboratory tests
Radiology procedures
Substances and virus
Prevention, treatment and education
Prevention
Prevention findings
Education
Medication
Note
The SNOMED CT subsets are provided as a guide only, and may need to be constrained or extended to meet local requirements.
Any SNOMED CT subset used to code COVID-19 data should be designed based on its purpose and the context in which it will be used.
To make the process of planning and designing your SNOMED CT subsets more efficient and internationally consistent, we recommend the following three steps.
These three steps are explained in more detail below.
The first step is to identify the data elements that may require SNOMED CT coding. These data elements may already be defined in national reporting requirements 123, as part of a healthcare data standard you are using (e.g. a HL7 FHIR profile4 or openEHR archetypes5), or you may be developing a new information model (or data set) for this purpose. Your requirements for coded content will depend on your specific use case and the data items in your information model. In addition, different countries, regions, and hospitals may apply different clinical techniques or practices, which can also result in differing coding requirements. Therefore, deciding which subsets to implement requires clarification of the scope of content needed, by answering questions such as:
As the global terminology for health, SNOMED CT can serve as a common language for recording, sharing, integrating and analyzing COVID-19 related data. This guide provides practical examples of SNOMED CT subsets that can be used to code a variety of COVID-19 related data elements, such as symptoms, risk factors and test results. These SNOMED CT subsets can be adapted to meet local requirements for healthcare service delivery, pandemic surveillance, international collaboration and retrospective data analysis. A set of computable also accompanies this guide.

Ethnic group
Racial group
Occupation
Travel history
Residential location type
Next of kin relationship
Living arrangements
Care and support circumstances
Diagnosis and certainty
Secondary conditions and complications
Potential risk factors
Comorbidities
Exposure event
Covid-19 and viral co-infections
Laboratory test results
Other investigations
Administrative procedures
Therapeutic procedures
Treatment findings
Treatment equipment

Will they be used to capture new data in a clinical information system to support frontline service delivery?
Will they be used for disease surveillance?
Will they be used to integrate data from various sources?
Will they be used for international collaboration?
Will they be used for retrospective analysis of data?
Which data elements are required for your use case?
What coded data needs to be collected to support clinical care?
What coded data needs to be collected to provide disease surveillance?
What coded data needs to be shared between or integrated from different sources?
What coded data is required for international collaboration?
What coded data may be needed for retrospective data analysis?
What existing subsets are available for the data elements of interest?
Where these subsets designed based on the same or compatible requirements?
Answering these questions will help in understanding which of the existing subsets are relevant for your context. It may also help to identify potential content gaps in the subsets, or extraneous concepts which are not required for your specific scenario. Please note that the questions above are provided for inspiration only. Additional questions specific to your use case are likely to be needed.
The second step is to download any available existing subsets that are associated with your required data elements.
The example COVID-19 subsets in this guide can be downloaded from Appendix A - Example Subsets.
The example COVID-19 subsets provided by SNOMED International have been named using the following convention.
SNOMED CT COVID-19 subsets:CV19- -
SNOMED CT COVID-19 subsets including subtypes of members:CV19- --withSubtypes
The table below shows some examples of subsets named using this convention.
Examples of Named Subset Category| Subset| Name Provider and Facility Details (PFD)| Site of care subset| CV19-PFD-SiteOfCare Patient Demographics (PAT)| Marital status subset| CV19-PAT-MaritalStatus Marital status subset including subtypes| CV19-PAT-MaritalStatus-withSubtypes Clinical Assessment (ASS)| Symptoms subset| CV19-ASS-Symptoms Symptoms subset including subtypes| CV19-ASS-Symptoms-withSubtypes
The international SNOMED CT subsets have been organized into a number of categories, based on groupings of data elements that are likely to be recorded together. The five categories identified are:
Provider and Facility Details (PFD)
Patient Demographics (PAT)
Clinical Assessment (ASS)
Tests and Investigations (INV)
Prevention, Treatment, and Education (PTE)
Please follow the links above for information on the specific subsets within each category.
Some of the international subsets have been developed intensionally, while others have been developed extensionally. Please refer to the Practical Guide to Reference Sets, section 2.1.1. Subset Definitions for information on the difference between intensionally and extensionally defined subsets.
For each extensionally-defined subset, where the members have subtypes, we provide two versions:
One subset which includes only the listed members. This version supports use cases (e.g. reporting, data integration) that require more abstract concepts.
One subset which includes the members listed and all the subtypes of each of these members. This version supports use cases that may require more specific values (e.g. data collection where more clinical detail is required).
Please note that this second type of subset is automatically generated from the corresponding subset with listed members. No manual curation has been performed, and therefore these subsets may contain concepts that are not relevant for the context of use.
The third step is to carefully review each international subset, and adapt it to meet your specific requirements. The subsets provided represent a collection of concepts that have been contributed from a range of SNOMED International Members. It is therefore important to review each subset member to:
Remove any concepts that are not required for your use case
Add any concepts missing from the subset that may be required for your specific use case
Please note, if the concept you require is not included in the SNOMED CT Edition you are using, please follow the content request processes in each country. For more information, refer to the relevant SNOMED International Member page.
SNOMED International National Release Centers and other authorized users may request additions or changes to the SNOMED CT International Edition via the SNOMED CT Content Request Service. For more information, refer to the CRS User Guide or contact .
Remove any concepts that are not included in the SNOMED CT versioned edition being used. This may involve
Checking the effective time of each international concept to ensure that it is less than or equal to the International Version used by your local SNOMED CT edition
Checking that any extension concepts are published in the SNOMED CT edition you are using
Ensure that your subset aligns with best practice principles for subset creation.
For example, this may involve checking that all members of the subset belong to a single hierarchy (in most cases), and that no two members subsume each other (in most cases).
Please note that the subsets in this guide may include some unpublished content that is planned for a future SNOMED CT edition. This content should not be used until it has been officially published, as we cannot guarantee that the identifiers or terms will not change. For this reason, these unpublished concepts are not included in the downloadable versions of the subsets. Unpublished concepts are included in this guide to assist with planning (e.g. planning of national extensions).
Unpublished content is shown in this guide using grey, italic font on a pink background, as shown in the example below.
In response to an immediate need for COVID-19-specific concepts, various Member countries have developed concepts within their national SNOMED CT Extensions. Please note, however, that extension concepts should only be used when the module in which they are published is included in the implemented SNOMED CT Edition. SNOMED CT extension concepts are not included in the subsets downloadable from the Reference Set tool.
SNOMED International welcomes comments on this guide and suggestions for new or updated content. Please use the Feedback button at the bottom of each page to send us your feedback.
Footnotes
1 "Coronavirus Disease 2019 (COVID-19)" , Centers for Disease Control and Prevention,https://www.cdc.gov/coronavirus/2019-ncov/php/reporting-pui.html
2 "COVID-19 Hospitalisation in England Surveillance System (CHESS) Daily Reporting,NHS - https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/phe-letter-to-trusts-re-daily-covid-19-hospital-surveillance-11-march-2020.pdf
3 HISO 10082:2020 Community Based Assessment Data Standard , Wellington: Ministry of Health 2020, New Zealand
5 openEHR Clinical Knowledge Manager (COVID-19 incubator)
IMPORTANT NOTE: This guide is no longer updated, and it is maintained only as a historical reference.
IMPORTANT NOTE: This guide is no longer updated, and it is maintained only as a historical reference.
© Copyright 2026 International Health Terminology Standards Development Organisation, all rights reserved.
This document is a publication of International Health Terminology Standards Development Organisation, trading as SNOMED International. SNOMED International owns and maintains SNOMED CT®.
Any modification of this document (including without limitation the removal or modification of this notice) is prohibited without the express written permission of SNOMED International. This document may be subject to updates. Always use the latest version of this document published by SNOMED International. This can be viewed online and downloaded by following the links on the front page or cover of this document.
SNOMED®, SNOMED CT® and IHTSDO® are registered trademarks of International Health Terminology Standards Development Organisation. SNOMED CT® licensing information is available at . For more information about SNOMED International and SNOMED International Membership, please refer to or contact us at .
IMPORTANT NOTE: This guide is no longer updated, and it is maintained only as a historical reference.
On March 11, 2020, the World Health Organization formally characterized coronavirus, COVID-19, as a global pandemic and health systems globally are continuing their efforts to manage the outbreak. Coronavirus disease COVID-19 is an infectious disease caused by a newly discovered coronavirus.
As part of the global effort to manage and contain this global public health emergency, SNOMED International is doing their part to support care teams and researchers in their efforts to address its containment. SNOMED International took swift action by publishing a set of coronavirus related concepts in the January 31st 2020 International Edition of SNOMED CT, with updated descriptions and SNOMED CT to ICD-10 maps in the interim March 2020 International Edition release. Since then, SNOMED International has published additional COVID-19 related content requested by the international community. This SNOMED CT Coronavirus Content will be made available as part of the Global Patient Set (GPS) in the September 2020 GPS release. In the meantime, this content is available and can be used under the same open license as the GPS, the Creative Commons Attribution 4.0 International License.
As the global terminology for health, SNOMED CT can serve as a common language for recording, sharing, integrating and analyzing COVID-19 related data. This guide provides practical examples of SNOMED CT subsets that can be used to code a variety of COVID-19 related data elements, such as symptoms, risk factors and test results. These SNOMED CT subsets can be adapted to meet local requirements for healthcare service delivery, pandemic surveillance, international collaboration and retrospective data analysis. A set of computable SNOMED CT subset artefacts also accompanies this guide.
For more information on performing data analytics using SNOMED CT please refer to Data Analytics with SNOMED CT. Additional guidance can be found in the SNOMED CT Document Library.
The scope of this document has been guided by the collective needs and experiences of our SNOMED International Members.
The primary focus of the guide is to provide example SNOMED CT subsets for data elements covering the following key areas:
Provider and facility details - e.g. healthcare profession, site of care, personal protective equipment
Patient demographics - e.g. biological sex, foreign travel history, living arrangements
Clinical assessment - e.g. symptoms, diagnosis, complications
These subsets provide examples of SNOMED CT concepts that may be used to code data elements in national reporting requirements, as part of a healthcare data standard (e.g. a HL7 FHIR profile or openEHR archetype), or a newly developed information model (data set). Before they can be used in a production system, these subsets should be carefully reviewed and updated to ensure that they fully meet the requirements of the intended use case.
The example subsets included in this guide use concepts that are in (or are planned to be added to) the SNOMED CT International Edition. This provides a foundation for international collaboration and research on COVID-19. Some examples of SNOMED CT extension concepts, added in National Editions of SNOMED CT, are also provided for a number of data elements. Please note that all concepts referenced in this guide should be used only in implementations where the relevant Edition is deployed.
The primary audience of this guide is the SNOMED National Release Centers (NRCs), who themselves may be required to provide national or regional guidance to their local implementations during or after the COVID-19 pandemic.
This guide has been developed in collaboration with our SNOMED National Release Centers (NRCs) and other Member representatives. We would like to thank you all for sharing your knowledge and experience to collectively help in the development of this COVID-19 guide.
The following references were used in the development of this guide.
, IFIC Basic Concepts of Infection Control (Chapter 6), 3rd edition, 2016, International Federation of Infection Control
, Centers for Disease Control and Prevention, U.S.
General demographic characteristics are important to record for each patient being investigated or treated for COVID-19. Relevant patient demographics, which can be recorded using SNOMED CT includes:
Biological sex
Gender identity
Treatment and education - e.g. vaccination, therapy
Coronavirus: what are asymptomatic and mild COVID-19?, Patient.info
COVID-19 Dataset Specification, Feidhmeannacht na Seirbhise Slainte, Health Service Executive, Ireland.
COVID-19 Penomics, UCL, Health Data Research UK.
COVID-19 Response Home, HL7 International
Emergency use ICD codes for COVID-19 disease outbreak , World Health Organization
Global Research on Coronavirus Disease (COVID-19), World Health Organization
Guidance document on appropriate management of suspect/confirmed cases of COVID-19 - Types of Covid-19 dedicated facilities, Ministry of Health and Family Welfare (MoHFW), Govt. of India
HISO 10082:2020 Community Based Assessment Data Standard , Wellington: Ministry of Health 2020, New Zealand
Holistic care for patients with severe coronavirus disease 2019: An expert consensus, International Journal of Nursing Sciences, Volume 7, Issue 2, 10 April 2020, Pages 128-134
Interoperability for COVID-19 Novel Coronavirus Pandemic , The Office of the National Coordinator for Health Information Technology, U.S.
Novel Coronavirus (COVID-19) Case Record Form, Global COVID-19 Clinical Platform, World Health Organization
openEHR Clinical Knowledge Manager (COVID-19 incubator)
Revised National Clinical Management Guidelines for COVID-19, Ministry of Health and Family Welfare (MoHFW), Govt. of India
SARS Coronavirus 2, Regenstrief Institute
SNOMED CT Coronavirus Content, _SNOMED International
Solidarity Clinical Trials for COVID-19 Treatment, World Health Organization
Standard Operating Procedure (SOP) for transporting a suspect/confirmed case of COVID-19, Ministry of Health and Family Welfare (MoHFW), Govt of India.


Nationality
Ethnic group
Racial group
Occupation
Travel history
Residential location type
Next of kin relationship
Living arrangements
Care and support circumstances
These data elements are described below, with example SNOMED CT subsets for each.
Multiple types of sex and/or gender are recorded in clinical practice, including biological sex and gender identity. 1
SNOMED CT supports the distinction between biological sex (e.g. 248152002 |Female (finding)| ) and gender identity (e.g. 703118005 |Feminine gender (finding)| ), as shown in the two subset definitions below.
CV19-PAT- BiologicalSex Intensional Definition : < 429019009 |Finding related to biological sex (finding)| MINUS << 302081005 |Finding of sex of baby (finding)|
CV19-PAT- GenderIdentity Intensional Definition : < 365873007 |Gender finding (finding)|
The marital or partnership status of a patient describes their legal, civil or personal relationship with their significant other, for example 87915002 | Married (finding)| .
CV19-PAT- MaritalOrPartnershipStatus Intensional Definition : < 365581002 |Finding of marital or partnership status (finding)|
Nationality refers to a particular legal relationship between an individual person and a sovereign state. The nationality of a patient may refer to the nation in which they were born, have citizenship, or have other legal ties - for example 223610001 | Jordan (geographic location)| or 223625001 | New Zealand (geographic location)| .
CV19-PAT- Nationality Intensional Definition : < 223369002 |Country (geographic location)|
The ethnic group (or ethnicity) of a patient is the social or cultural group with whom they identify - for example, 33897005 |Chinese (ethnic group)| or 735001008 |Scandinavian (ethnic group)| .
CV19-PAT- EthnicGroup Intensional Definition : < 372148003 |Ethnic group (ethnic group)|
The racial group (or race) of a patient is the group (or groups) with whom they share inherited physical characteristics - for example, 414408004 |Hispanic (racial group)| or 413773004 |Caucasian (racial group)| .
CV19-PAT- RacialGroup Intensional Definition : < 415229000 |Racial group (racial group)|
Occupation is the patient's job or profession - for example, 158942005 | Residential child care worker (occupation)| or 308223007 | Hairdresser (occupation)| .
CV19-PAT- Occupation Intensional Definition : < 14679004 |Occupation (occupation)|
The travel history of a patient is a record of their past visits to locations both inside and outside their country of residence. This may include a list of the specific countries and/or regions that they have travelled to (e.g. 223498002 | Africa (geographic location)| or 223585008 | South east Asian country (geographic location)| ), or a descriptive travel history finding (e.g. 161090005 | Travel abroad for business (finding)| ).
CV19-PAT-TravelHistory Intensional Definition : < 223496003 |Geographical and/or political region of the world (geographic location)| OR < 365457007 |Foreign travel history finding (finding)| OR < 420008001 |Travel (event)|
The residential location type is the type of place in which the patient is currently living, or was living prior to admission to hospital - for example, 257564005 | Apartment (environment)| or 257670006 | Private house (environment)| .
CV19-PAT- ResidentialLocationType Intensional Definition : < 272497004 |Residential environment (environment)|
The next of kin relationship is the relationship that the patient has with their closest living relative (as chosen by the patient) - for example 444053001 | Husband of subject (person)| or 444301002 | Mother of subject (person)| .
CV19-PAT- NextOfKinRelationship Intensional Definition : < 444148008 |Person in family of subject (person)|
The living arrangements of the patient describes the familial and non-familial relationships of a person to all the other people with whom they usually reside - for example 105529008 | Lives alone (finding)| or 224133007 | Lives with family (finding)| .
CV19-PAT- LivingArrangements Intensional Definition : < 365481000 |Finding of household composition (finding)|
The care and support circumstances of the patient describe how and by whom they are looked after when living at their usual place of residence - for example 427454004 | Cared for by neighbors (finding)| or 301887005 | Needs assistance at home (finding)| .
CV19-PAT- CareAndSupportCircumstances Intensional Definition : < 365483002 |Finding related to care and support circumstances and networks (finding)|
Footnotes


Laboratory testing for COVID-19 and the associated SARS-CoV-2 virus includes methods that detect the presence of the virus and antibodies produced in response to infection, in specimen samples taken from potentially infected individuals. Test and investigation data which can be recorded using SNOMED CT includes:
Specimen
Laboratory Tests
Radiology Procedures
Substances and Virus
Laboratory Test Results
Other Investigations
These data elements are described below, with example SNOMED CT subsets for each.
Specimens are samples of substances taken from an individual for testing - for example or . The following specimens may be relevant to COVID-19 testing in one or more countries affected by the virus.
CV19-INV-Specimen
The specimens prefixed with a star '*' are a subtype of another member of this subset.
Laboratory tests can be performed to detect the presence of the COVID-19 virus and antibodies produced in response to this virus. The following SNOMED CT concepts can be used to record laboratory tests that may be performed during the investigation process.
CV19-INV-LaboratoryTests
Radiology procedures are procedures that obtain images of the inside of the body. The following SNOMED CT concepts may be used to record radiology procedures that may be performed during the investigation and treatment of suspected or confirmed Covid-19 patients.
CV19-INV-RadiologyProcedures
An antibody is a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. The following antibody/antigen and virus organism concepts can be used to record the focus of a COVID-19 investigation.
CV19-INV-SubstancesAndVirus
Laboratory test results are used to specify whether the Laboratory test focus was detected or not detected following the conducted laboratory test. The following qualifier values may be used for this purpose.
CV19-INV-LabTestResults
Other investigative procedures - e.g. and and and - may be performed to assess a COVID-19 patient. The following subset represents procedures that can be performed during the clinical assessment process.
The following subset represents a collection of findings with context that may be related to these investigations and captured using SNOMED CT - for example or .
Footnotes
1 , Division of Laboratory Systems, CDC, US
2 , The Native Antigen Company, UK
119297000
Blood specimen (specimen)
Blood specimen
20040731
*
258607008
Bronchoalveolar lavage fluid sample (specimen)
Bronchoalveolar lavage fluid sample
20080731
*
122554006
Capillary blood specimen (specimen)
Capillary blood specimen
20080731
*
119294007
Dried blood specimen (specimen)
Dried blood specimen
20020131
168137004
Gastric aspirate sample (specimen)
Gastric aspirate sample
20060131
258606004
Lower respiratory sample (specimen)
Lower respiratory sample
20080731
258411007
Nasopharyngeal aspirate (specimen)
Nasopharyngeal aspirate
20080731
258500001
Nasopharyngeal swab (specimen)
Nasopharyngeal swab
20080731
258412000
Oropharyngeal aspirate (specimen)
Oropharyngeal aspirate
20080731
418564007
Pleural fluid specimen (specimen)
Pleural fluid specimen
20080731
119342007
Saliva specimen (specimen)
Saliva specimen
20040731
*
119364003
Serum specimen (specimen)
Serum specimen
20050131
734427005
Specimen from duodenum obtained by aspiration (specimen)
Specimen from duodenum obtained by aspiration
20180131
122610009
Specimen from lung obtained by biopsy (specimen)
Specimen from lung obtained by biopsy
20080731
445447003
Specimen from trachea obtained by aspiration (specimen)
Specimen from trachea obtained by aspiration
20100731
119334006
Sputum specimen (specimen)
Sputum specimen
20080731
119339001
Stool specimen (specimen)
Stool specimen
20030731
*
472901003
Swab from nasal sinus (specimen)
Swab from nasal sinus
20130131
445297001
Swab of internal nose (specimen)
Swab of internal nose
20100731
*
871810001
Swab specimen from nasal mid-turbinate (specimen)
Mid-turbinate nasal swab
20200731
461911000124106
Swab specimen from oropharynx (specimen)
Oropharyngeal swab
20200731
258529004
Throat swab (specimen)
Throat swab
20080731
122877000
Upper respiratory fluid specimen obtained by tracheal aspiration (specimen)
Upper respiratory fluid specimen obtained by tracheal aspiration
20040731
309164002
Upper respiratory swab sample (specimen)
Upper respiratory swab sample
20080731
122575003
Urine specimen (specimen)
Urine specimen
20080731
*
258580003
Whole blood sample (specimen)
Whole blood sample
20080731
Analysis of arterial blood gases and pH (procedure)
Analysis of arterial blood gases and pH
20020131
444077007
Analysis using reverse transcriptase polymerase chain reaction technique (procedure)
Analysis using reverse transcriptase PCR
20100131
61911006
Blood gases, venous measurement (procedure)
Blood gases, venous measurement
20020131
871555000
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 (observable entity)
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2
20200731
871559006
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in bronchoalveolar lavage fluid (observable entity)
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in bronchoalveolar lavage fluid
20200731
871556004
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in nasopharyngeal swab (observable entity)
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in nasopharyngeal swab
20200731
871557008
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in oropharyngeal swab (observable entity)
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in oropharyngeal swab
20200731
871558003
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in sputum (observable entity)
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in sputum
20200731
871560001
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 using polymerase chain reaction (observable entity)
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 using polymerase chain reaction
20200731
871562009
Detection of Severe acute respiratory syndrome coronavirus 2 (observable entity)
Detection of Severe acute respiratory syndrome coronavirus 2
20200731
871553007
Detection of Severe acute respiratory syndrome coronavirus 2 antigen (observable entity)
Detection of Severe acute respiratory syndrome coronavirus 2 antigen
20200731
76978006
Enzyme-linked immunosorbent assay (procedure)
Enzyme-linked immunosorbent assay
20080731
30662005
Fluorescent immunoassay (procedure)
Fluorescent immunoassay
20020131
414464004
Immunoassay method (procedure)
Immunoassay method
20050131
1240461000000109
Measurement of severe acute respiratory syndrome coronavirus 2 antibody (observable entity)
Measurement of severe acute respiratory syndrome coronavirus 2 antibody
20200731
1240471000000102
Measurement of severe acute respiratory syndrome coronavirus 2 antigen (observable entity)
Measurement of severe acute respiratory syndrome coronavirus 2 antigen
20200731
122435008
Measurement of viral antibody (procedure)
Measurement of viral antibody
20100131
9718006
Polymerase chain reaction analysis (procedure)
Polymerase chain reaction analysis
20080731
122433001
Viral antigen assay (procedure)
Viral antigen assay
20050131
118147004
Viral nucleic acid assay (procedure)
Viral nucleic acid assay
20020131
88667002
Viral serologic study (procedure)
Viral serologic study
20150131
Computed tomography of chest (procedure)
CT of chest
20040731
399208008
Plain chest X-ray (procedure)
Plain chest X-ray
20050131
88628008
Ultrasonography of lung (procedure)
Ultrasonography of lung
20020131
Antigen of severe acute respiratory syndrome coronavirus 2 (substance)
Antigen of SARS-CoV-2
20200131
870361009
Immunoglobulin G antibody to Severe acute respiratory syndrome coronavirus 2 (substance)
SARS-CoV-2 IgG
20200731
870362002
Immunoglobulin M antibody to Severe acute respiratory syndrome coronavirus 2 (substance)
SARS-CoV-2 IgM
20200731
1155866009
Messenger ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 encoding spike protein (substance)
SARS-CoV-2 mRNA encoding spike protein
20210731
1119343008
Messenger ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 (substance)
Severe acute respiratory syndrome coronavirus 2 mRNA
20210131
1240411000000107
Ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 (substance)
Severe acute respiratory syndrome coronavirus 2 RNA
20200731
840533007
Severe acute respiratory syndrome coronavirus 2 (organism)
SARS-CoV-2
20200131
Inconclusive (qualifier value)
Inconclusive
20060131
260415000
Not detected (qualifier value)
Not detected
20020131
895231008
Not detected in pooled specimen (qualifier value)
Not detected in pooled specimen
20200731
897035006
Severe acute respiratory syndrome coronavirus 2 antibody test negative (finding)
SARS-CoV-2 antibody test negative
20210131
897034005
Severe acute respiratory syndrome coronavirus 2 antibody test positive (finding)
SARS-CoV-2 antibody test positive
20210131
1240581000000104
Severe acute respiratory syndrome coronavirus 2 detected (finding)
Severe acute respiratory syndrome coronavirus 2 detected
20200731
1240591000000102
Severe acute respiratory syndrome coronavirus 2 not detected (finding)
Severe acute respiratory syndrome coronavirus 2 not detected
20200731
125154007
Specimen unsatisfactory for evaluation (finding)
Specimen unsatisfactory for evaluation
20020131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
*
697989009
Anterior nares swab (specimen)
Anterior nares swab
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
16332841000119106
Computed tomography angiography of pulmonary artery with contrast (procedure)
CT angiography of pulmonary artery with contrast
20170131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
840535000
Antibody to severe acute respiratory syndrome coronavirus 2 (substance)
Antibody to SARS-CoV-2
20200131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
260373001
Detected (qualifier value)
Detected
20020131
CV19-INV-InvestigationProcedures
Intensional Definition:
< 386053000 |Evaluation procedure (procedure)| OR < 308335008 |Patient encounter procedure (procedure)| OR < 17636008 |Specimen collection (procedure)|
CV19-INV-InvestigationFindings
Intensional Definition:
< 313333008 |Sample obtained (situation)| OR < 168123008 |Sample sent for examination (situation)|

20140131
60170009
169069000
840536004
419984006
Preventing the potential spread of COVID-19 can involve a range of precautions, such as isolation and the wearing of personal protective equipment, and education to patients, healthcare workers and the broader community. Once COVID-19 is diagnosed, various treatments may be considered, together with education for the patient and their families/caregivers
Prevention
Prevention Findings
Education
Medication
Administrative Procedures
Therapeutic Procedures
Treatment Findings
Treatment Equipment
These data elements are described below, with example SNOMED CT subsets where applicable.
Precautionary measures, such as , , and are extremely important in the fight against infectious diseases such as COVID-19. The following preventative measures can be recorded using SNOMED CT.
CV19-PTE-PreventionProcedures
Clinical findings (or situations) relating to the COVID-19 preventative measures performed may be captured in a health record. The following prevention findings (or situations) may be recorded using SNOMED CT.
CV19-PTE-PreventionFindings
Education is an important aspect of preventing and managing COVID-19 infection. The following SNOMED CT concepts may be used to record this data.
CV19-PTE-Education
A number of countries are trialling the use of medication to treat COVID-19. Many of these medications can be found in the hierarchy of SNOMED CT. However until there is sufficient evidence, the WHO is cautioning against associations recommending or administering these unproven treatments to patients with COVID-19 or people self-medicating with them. For this reason, we have not included a medication treatment subset at this time.
COVID-19 vaccines, however, have been proven to be effective in clinical trials. The following generic vaccine concepts may be recorded using SNOMED CT.
CV19-PTE-Vaccines
Patients with severe symptoms or complications may require admission to hospital, or other administrative procedures. The following administrative procedures may be recorded using SNOMED CT.
CV19-PTE-AdministrativeProcedures
Patients suffering from severe COVID-19 symptoms or complications may require a range of therapeutic procedures, many of them involving supportive care to help them breathe. The following therapeutic procedures may be recorded using SNOMED CT.
CV19-PTE-TherapeuticProcedures
Clinical findings relating to the treatment performed on a patient may be captured in a health record. The following treatment findings may be recorded using SNOMED CT.
CV19-PTE-TreatmentPreventionFindings
Respiratory equipment includes those medical devices used to support breathing and respiratory function - for example , and .
Footnotes
1 , IFIC Basic Concepts of Infection Control (Chapter 6), 3rd edition, 2016, International Federation of Infection Control
2
Administration of first dose of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)
Administration of first dose of SARS-CoV-2 mRNA vaccine
20210131
1157197009
Administration of second dose of vaccine product containing only inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Administration of second dose of inactivated whole SARS-CoV-2 antigen vaccine
20210731
1157108008
Administration of second dose vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (procedure)
Administration of second dose SARS-CoV-2 non-replicating viral vector vaccine
20210731
1144998002
Administration of second dose of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)
Administration of second dose of SARS-CoV-2 mRNA vaccine
20210131
1162646009
Administration of second dose of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)
Administration of second dose of SARS-CoV-2 recombinant spike protein antigen vaccine
20210731
1156257007
Administration of vaccine product against Severe acute respiratory syndrome coronavirus 2 (procedure)
Administration of SARS-CoV-2 vaccine
20210731
1157107003
Administration of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (procedure)
Administration of SARS-CoV-2 non-replicating viral vector vaccine
20210731
840534001
Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Administration of SARS-CoV-2 antigen vaccine
20210131
1119350007
Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)
Administration of SARS-CoV-2 mRNA vaccine
20210131
1162645008
Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)
Administration of SARS-CoV-2 recombinant spike protein antigen vaccine
20210731
409524006
Airborne precautions (procedure)
Airborne precautions
20040731
422181004
Antibiotic prophylaxis (procedure)
Antibiotic prophylaxis
20060731
449399005
Application of personal protective equipment (procedure)
Application of personal protective equipment
20110731
386242000
Communicable disease management (procedure)
Communicable disease management
20030131
225368008
Contact tracing (procedure)
Contact tracing
20020131
409529001
Contact precautions (procedure)
Contact precautions
20040731
409686004
Disinfecting of equipment (procedure)
Disinfecting of equipment
20040731
449390009
Ensuring use of supplies and equipment within safe parameters (procedure)
Ensuring use of supplies and equipment within safe parameters
20110731
122467006
Fitting procedure (procedure)
Fitting procedure
20020131
77248004
Infection control procedure (procedure)
Infection control procedure
20020131
370832005
Initiation of traffic control (procedure)
Initiation of traffic control
20020731
361235007
Isolation of infected patient (procedure)
Isolation of infected patient
20020131
170499009
Isolation of infection contact (procedure)
Isolation of infection contact
20020131
170500000
Isolation of infection carrier (procedure)
Isolation of infection carrier
20020131
40174006
Isolation procedure (procedure)
Isolation technique
20020131
225995005
Maintaining a safe environment (procedure)
Maintaining a safe environment
20020131
275827007
Maintaining asepsis (procedure)
Maintaining asepsis
20020131
38883000
Preoperative disinfection of skin (procedure)
Preoperative disinfection of skin
20020131
29537000
Preoperative shaving of skin (procedure)
Preoperative shaving of skin
20080131
736762004
Provision of personal protective equipment (procedure)
Provision of personal protective equipment
20180131
409525007
Respiratory secretion precautions (procedure)
Respiratory secretion precautions
20040731
410410006
Screening surveillance (regime/therapy)
Screening surveillance
20040731
409522005
Standard precautions (procedure)
Standard precautions
20040731
409684001
Sterilization of equipment (procedure)
Sterilization of equipment
20040731
409583003
Transmission-based precautions (procedure)
Transmission-based precautions
20040731
243791004
Viral screening (procedure)
Viral screening
20080131
Adverse reaction to component of vaccine product containing only inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen (disorder)
Adverse reaction to inactivated whole COVID-19 antigen vaccine
20210731
1157106007
Adverse reaction to component of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (disorder)
Adverse reaction to COVID-19 non-replicating viral vector vaccine
20210731
1142182006
Adverse reaction to component of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 antigen (disorder)
Adverse reaction to COVID-19 antigen vaccine
20210131
1142181004
Adverse reaction to component of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (disorder)
Adverse reaction to COVID-19 mRNA vaccine
20210131
1162644007
Adverse reaction to component of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (disorder)
Adverse reaction to COVID-19 recombinant spike protein antigen vaccine
20210731
1145003007
Hypersensitivity to vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (finding)
Hypersensitivity to SARS-CoV-2 mRNA vaccine
20210131
1157198004
Inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen vaccine contraindicated (situation)
Inactivated whole SARS-CoV-2 antigen vaccine contraindicated
20210731
1157200005
Inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen vaccine declined (situation)
Inactivated whole SARS-CoV-2 antigen vaccine declined
20210731
1157199007
Second dose of inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen vaccine contraindicated (situation)
Second dose of inactivated whole SARS-CoV-2 antigen vaccine contraindicated
20210731
1157201009
Second dose of inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen vaccine declined (situation)
Second dose of inactivated whole SARS-CoV-2 antigen vaccine declined
20210731
1145035007
Second dose of Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine contraindicated (situation)
Second dose of SARS-CoV-2 mRNA vaccine contraindicated
20210131
1145034006
Second dose of Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine declined (situation)
Second dose of SARS-CoV-2 mRNA vaccine declined
20210131
1157113007
Second dose of Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine contraindicated (situation)
Second dose of SARS-CoV-2 non-replicating viral vector vaccine contraindicated
20210731
1157120000
Second dose of Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine declined (situation)
Second dose of SARS-CoV-2 non-replicating viral vector vaccine declined
20210731
1162648005
Second dose of Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine contraindicated (situation)
Second dose of recombinant spike protein SARS-CoV-2 antigen vaccine contraindicated
20210731
1162650002
Second dose of Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine declined (situation)
Second dose of SARS-CoV-2 recombinant spike protein antigen vaccine declined
20210731
1145031003
Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine declined (situation)
SARS-CoV-2 vaccine declined
20210131
1145023008
Severe acute respiratory syndrome coronavirus 2 antigen vaccine contraindicated (situation)
SARS-CoV-2 antigen vaccine contraindicated
20210131
1145033000
Severe acute respiratory syndrome coronavirus 2 antigen vaccine declined (situation)
SARS-CoV-2 antigen vaccine declined
20210131
1145030002
Severe acute respiratory syndrome coronavirus 2 antigen vaccination not indicated (situation)
SARS-CoV-2 antigen vaccination not indicated
20210131
1145022003
Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine contraindicated (situation)
SARS-CoV-2 mRNA vaccine contraindicated
20210131
1145032005
Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine declined (situation)
SARS-CoV-2 mRNA vaccine declined
20210131
1145029007
Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination not indicated (situation)
SARS-CoV-2 mRNA vaccination not indicated
20210131
1157110005
Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine contraindicated (situation)
SARS-CoV-2 non-replicating viral vector vaccine contraindicated
20210731
1157118003
Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine declined (situation)
SARS-CoV-2 non-replicating viral vector vaccine declined
20210731
1162647000
Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine contraindicated (situation)
SARS-CoV-2 recombinant spike protein antigen vaccine contraindicated
20210731
1162649002
Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine declined (situation)
SARS-CoV-2 recombinant spike protein antigen vaccine declined
20210731
1156270003
Severe acute respiratory syndrome coronavirus 2 vaccination declined (situation)
SARS-CoV-2 vaccination declined
20210731
1156267002
Severe acute respiratory syndrome coronavirus 2 vaccination not indicated (situation)
SARS-CoV-2 vaccination not indicated
20210731
1156265005
Severe acute respiratory syndrome coronavirus 2 vaccine contraindicated (situation)
SARS-CoV-2 vaccine contraindicated
20210731
1156746003
Vaccine-induced prothrombotic immune thrombocytopenia (disorder)
Vaccine-induced prothrombotic immune thrombocytopenia
20210731
Education about infectious disease (procedure)
Education about infectious disease
20200731
223426009
Equipment use education (procedure)
Equipment use education
20020131
698608004
Hand washing education (procedure)
Hand washing education
20140131
385820004
Infection control education (procedure)
Infection control education
20100731
Vaccine product containing only inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen (medicinal product)
Inactivated whole SARS-CoV-2 antigen vaccine
20210731
29061000087103
Vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (medicinal product)
COVID-19 non-replicating viral vector vaccine
20210731
1119305005
Vaccine product containing only Severe acute respiratory syndrome coronavirus 2 antigen (medicinal product)
Severe acute respiratory syndrome coronavirus 2 antigen only vaccine product
20210131
1119349007
Vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product)
Severe acute respiratory syndrome coronavirus 2 mRNA only vaccine product
20210131
1162643001
Vaccine product containing only Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (medicinal product)
SARS-CoV-2 recombinant spike protein antigen vaccine
20210731
Admission to infectious diseases department (procedure)
Admission to infectious diseases department
20020131
305351004
Admission to intensive care unit (procedure)
Admission to intensive care unit
20020131
305360007
Admission to respiratory medicine department (procedure)
Admission to respiratory medicine department
20020131
32485007
Hospital admission (procedure)
Hospital admission
20020131
417005
Hospital re-admission (procedure)
Hospital re-admission
20020131
107724000
Patient transfer (procedure)
Patient transfer
20020131
397821002
Patient transfer to intensive care unit (procedure)
Patient transfer to intensive care unit
20030731
710112000
Transfer of care from hospital (procedure)
Transfer of care from hospital
20150731
429202003
Transfer of care to hospital (procedure)
Transfer of care to hospital
20080131
Extracorporeal membrane oxygenation (procedure)
Extracorporeal membrane oxygenation
20020131
697984004
Exteriorization of trachea (procedure)
Exteriorization of trachea
20140131
229301009
Incentive spirometry (regime/therapy)
Incentive spirometry
20020131
829831000000100
Insertion of fiducial marker into lung using computed tomography guidance (procedure)
Insertion of fiducial marker into lung using computed tomography guidance
20200731
447996002
Intubation of respiratory tract (procedure)
Intubation of respiratory tract
20110731
243141005
Mechanically assisted spontaneous ventilation (procedure)
Mechanically assisted spontaneous ventilation
20020131
428311008
Noninvasive ventilation (procedure)
Noninvasive ventilation
20080131
371908008
Oxygen administration by mask (procedure)
Oxygen administration by mask
20020731
371907003
Oxygen administration by nasal cannula (procedure)
Oxygen administration by nasal cannula
20020731
431182000
Placing subject in prone position (procedure)
Placing subject in prone position
20080731
11140008
Respiratory assist, manual (procedure)
Respiratory assist, manual
20020131
1156748002
Transfusion of convalescent plasma into central vein (procedure)
Transfusion of convalescent plasma into central vein
20210731
1156747007
Transfusion of convalescent plasma into peripheral vein (procedure)
Transfusion of convalescent plasma into peripheral vein
20210731
Dependence on supplemental oxygen (finding)
Dependence on supplemental oxygen
20120731
444932008
Dependence on ventilator (finding)
Dependence on ventilator
20100731
763326004
Difficult mask ventilation (finding)
Difficult mask ventilation
20180731
718447001
Difficult tracheal intubation (finding)
Difficult intubation
20160731
419991009
Endotracheal tube present (finding)
Endotracheal tube present
20060131
405496006
Inability to ventilate patients lungs mechanically (finding)
Inability to ventilate patients lungs mechanically
20040131
22803001
Normal respiratory function (finding)
Normal respiratory function
20020131
371825009
Patient on oxygen (finding)
Patient on oxygen
20020731
371820004
Patient ventilated (finding)
Patient ventilated
20020731
718085007
Unable to intubate and unable to ventilate (finding)
Cannot intubate cannot ventilate
20160731
128258000
Ventilation finding (finding)
Ventilation finding
20020131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
1157196000
Administration of vaccine product containing only inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Administration of inactivated whole SARS-CoV-2 antigen vaccine
20210731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
1156256003
Adverse reaction to component of vaccine product against Severe acute respiratory syndrome coronavirus 2 (disorder)
Adverse reaction to COVID-19 vaccine
20210731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
736017006
Education about hand hygiene (procedure)
Education about hand hygiene
20180131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
28531000087107
Vaccine product against Severe acute respiratory syndrome coronavirus 2 (medicinal product)
COVID-19 vaccine
20210731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
183452005
Emergency hospital admission (procedure)
Emergency hospital admission
20020131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
40617009
Artificial respiration (procedure)
Artificial respiration
20020131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
79031000119101
Dependence on respirator (finding)
Dependence on respirator
20150731
CV19-PTE-TreatmentEquipment
Intensional Definition:
< 277973009 |Respiratory equipment (physical object)| OR < 336589003 |Oxygen equipment (physical object)| OR < 334943003 |Respiratory appliances (physical object)| OR < 304077006 |Respiratory system device (physical object)| OR < 706167001 |Anesthesia and respiratory device (physical object)|

1144997007
1157195001
868263005
1157024006
305376003
233573008
931000119107
The first step in delivering comprehensive care is to undertake a clinical assessment. Clinical assessment data which can be recorded using SNOMED CT includes:
Symptoms
Severity
Clinical Measurements
Clinical Examination Findings
Diagnosis and Certainty
Clinical History
Secondary Conditions and Complications
Potential Risk Factors
Comorbidities
Exposure Event
Covid-19 and Viral Co-Infections
These data elements are described below, with example SNOMED CT subsets for each.
Please note that all published concepts referred to on this page are included in SNOMED International's , which is available to be used internationally under the . Please refer to for more information.
Symptoms represent physical or mental features which are regarded as an indication of a condition or disease, particularly those features that are apparent to the patient. This SNOMED CT subset of COVID-19 symptoms has been developed based on a range of literature, including relevant articles found in Pubmed, research performed by Kings College London, and a review of COVID-19 data collection forms. Please note that this subset includes the concept , which can be used to represent the absence of symptoms.
CV19-ASS-Symptoms
Severity represents the quality of the condition - for example, . Severity may be recorded for each symptom, or as a general statement of their disease state 4.
CV19-ASS-Severity
Clinical measurements involve the performance of physiological tests to diagnose and refine therapeutic management of an already established disease. The following clinical measurements (and related observables) can be used in the assessment of a COVID-19 patient.
CV19-ASS- ClinicalMeasurements
Clinical examination findings are the result of measuring, questioning, evaluating, or otherwise examining a patient in healthcare. The following clinical findings are positive or negative indications that signs are present in a COVID-19 patient.
CV19-ASS-ClinicalExaminationFindings
A diagnosis is the identification of the nature of the illness, based on an examination of the symptoms, observations, measurements, test results and other investigation results. The following subset includes a range of diagnoses directly related to COVID-19.
CV19-ASS-Diagnosis
To represent the certainty of a positive COVID-19 diagnosis, the following subset may be used in conjunction with a diagnosis of .
CV19-ASS-DiagnosisPresentCertainty
To represent the certainty of the absence of COVID-19, the following subset may be used in conjunction with a diagnosis of .
CV19-ASS-DiagnosisAbsentCertainty
The clinical history concepts are used to record information gained by a physician by asking specific questions, either of the patient or of other people who know the person and can give suitable information, with the aim of obtaining information useful in formulating a diagnosis and providing medical care to the patient.
CV19-ASS-ClinicalHistory
A secondary condition is any additional health condition that occurs as a result of the natural progression or expected outcome of the primary condition. A complication is "a disorder caused by another disorder, procedure or event, which is not a natural progression or expected outcome of its cause .
The following subset includes SNOMED CT clinical findings that may be recorded as either secondary conditions or complications . Clinical judgement is required to determine whether these conditions are expected outcomes or unexpected complications of COVID-19.
CV19-ASS-SecondaryConditionsAndComplications
Potential risk factors are the patient conditions which may influence the course or outcomes of the COVID-19 disease. The following clinical findings may be recorded as potential risk factors.
CV19-ASS-RiskFactors
Similarly, procedures performed on the patient within a clinically relevant timeframe may also influence the course or outcomes of the COVID-19 disease. The following procedures may be recorded as potential risk factors.
CV19-ASS-ProcedureRiskFactors
Comorbidities are additional medical conditions of concern. The following SNOMED CT subset can be used to record comorbidities.
An exposure event is when an individual comes into close contact with an infected person's contaminated droplets, carried in the air or on contaminated hands, surfaces or other objects. The subset below includes SNOMED CT events for recording exposure to COVID-19.
CV19-ASS-ExposureEvent
An exposure finding is the result of an observation or evaluation that relates to the patient's exposure to an infection. The subset below includes SNOMED CT findings relating to COVID-19 exposure.
CV19-ASS-ExposureFinding
The following organism should be used when recording the organism causing COVID-19 infections.
CV19-ASS-Organism
The following organisms can be used to record the cause of related viral co-infections.
Footnotes
1 Articles found using the Pubmed query ""
2
3 COVID-19 Case Reporting Forms, including: , CDC, US , Global COVID-19 Clinical Platform, World Health Organization , NHS, UK
4 , Patient.info , Patient.info
5 , SNOMED International
6 Clinical papers, including:
7
8 , NHS, UK
9 , NHS, UK
Bleeding (finding)
Bleeding
20050131
29857009
Chest pain (finding)
Chest pain
20040731
43724002
Chill (finding)
Chill
20020131
82272006
Common cold (disorder)
Common cold
20030131
9826008
Conjunctivitis (disorder)
Conjunctivitis
20040731
49727002
Cough (finding)
Cough
20020131
3415004
Cyanosis (finding)
Cyanosis
20020131
62315008
Diarrhea (finding)
Diarrhea
20020131
3006004
Disturbance of consciousness (finding)
Disturbance of consciousness
20020131
267036007
Dyspnea (finding)
Dyspnea
20020131
271807003
Eruption of skin (disorder)
Eruption
20020731
84229001
Fatigue (finding)
Fatigue
20020131
103001002
Feeling feverish (finding)
Feeling feverish
20020131
386661006
Fever (finding)
Fever
20030131
25064002
Headache (finding)
Headache
20100131
66857006
Hemoptysis (finding)
Hemoptysis
20020131
248567008
Indrawing of ribs during respiration (finding)
Indrawing of ribs during respiration
20020131
57676002
Joint pain (finding)
Joint pain
20020131
79890006
Loss of appetite (finding)
Loss of appetite
20020131
44169009
Loss of sense of smell (finding)
Loss of sense of smell
20200131
36955009
Loss of taste (finding)
Loss of taste
20020131
30746006
Lymphadenopathy (disorder)
Lymphadenopathy
20020131
367391008
Malaise (finding)
Malaise
20020131
68962001
Muscle pain (finding)
Muscle pain
20020131
26544005
Muscle weakness (finding)
Muscle weakness
20020131
68235000
Nasal congestion (finding)
Nasal congestion
20020131
64531003
Nasal discharge (finding)
Nasal discharge
20020131
422587007
Nausea (finding)
Nausea
20070131
44077006
Numbness (finding)
Numbness
20170731
162397003
Pain in throat (finding)
Pain in throat
20020131
38880002
Rigor (finding)
Rigor
20020131
91175000
Seizure (finding)
Seizure
20020131
46742003
Skin ulcer (disorder)
Skin ulcer
20020131
23924001
Tight chest (finding)
Tight chest
20020131
282145008
Unable to walk (finding)
Unable to walk
20080731
422400008
Vomiting (disorder)
Vomiting
20180731
56018004
Wheezing (finding)
Wheezing
20020131
Moderate (severity modifier) (qualifier value)
Moderate
20020131
24484000
Severe (severity modifier) (qualifier value)
Severe
20020131
442452003
Life threatening severity (qualifier value)
Life threatening severity
20090731
Body temperature (observable entity)
Body temperature
20170131
75367002
Blood pressure (observable entity)
Blood pressure
20170131
248592006
Character of cough (observable entity)
Character of cough
20020131
364533002
Color of skin (observable entity)
Color of skin
20020131
709017009
Compliance behavior to safety precaution (observable entity)
Compliance behavior to safety precaution
20150731
263731006
Coughing (observable entity)
Coughing
20020131
271626009
Depth of respiration (observable entity)
Depth of respiration
20020131
226379006
Food intake (observable entity)
Food intake
20020131
364075005
Heart rate (observable entity)
Heart rate
20170131
103228002
Hemoglobin saturation with oxygen (observable entity)
Hemoglobin saturation with oxygen
20020131
6942003
Level of consciousness (observable entity)
Level of consciousness
20020131
440398005
Level of fatigue (observable entity)
Level of fatigue
20090131
405161002
Pain level (observable entity)
Pain level
20040131
248750004
Peripheral blood flow (observable entity)
Peripheral blood flow
20020131
431314004
Peripheral oxygen saturation (observable entity)
Peripheral oxygen saturation
20080731
8499008
Pulse, function (observable entity)
Pulse
20020131
248565000
Respiratory effort (observable entity)
Respiratory effort
20020131
86290005
Respiratory rate (observable entity)
Respiratory rate
20170131
248582003
Rhythm of respiration (observable entity)
Rhythm of respiration
20020131
247433003
Skin elasticity (observable entity)
Skin elasticity
20020131
248598005
Sputum volume (observable entity)
Sputum volume
20020131
442349007
Venous oxygen saturation (observable entity)
Venous oxygen saturation
20090731
Activity intolerance (finding)
Activity intolerance
20020131
20262006
Ataxia (finding)
Ataxia
20020131
371632003
Coma (disorder)
Coma
20020731
193894004
Conjunctival hyperemia (finding)
Conjunctival hyperemia
20100131
58840004
Decreased breath sounds (finding)
Decreased breath sounds
20020131
443371007
Decreased level of consciousness (finding)
Decreased level of consciousness
20100131
9763007
Expiratory wheezing (finding)
Expiratory wheezing
20020131
126664009
Exudative pharyngitis (disorder)
Exudative pharyngitis
20020131
386661006
Fever (finding)
Fever
20030131
442646005
Imaging of lung abnormal (finding)
Imaging of lung abnormal
20090731
67750007
Ineffective airway clearance (finding)
Ineffective airway clearance
20020131
70944005
Impaired gas exchange (finding)
Impaired gas exchange
20080731
75252003
Inspiratory crackles (finding)
Inspiratory crackles
20020131
419045004
Loss of consciousness (finding)
Loss of consciousness
20060131
274710003
Lung field abnormal (finding)
Lung field abnormal
20020131
91175000
Seizure (finding)
Seizure
20020131
3424008
Tachycardia (finding)
Tachycardia
20080731
271823003
Tachypnea (finding)
Tachypnea
20020131
288849009
Unable to breathe (finding)
Unable to breathe
20080731
Asymptomatic severe acute respiratory syndrome coronavirus 2 infection (finding)
Asymptomatic SARS-CoV-2
20200731
840539006
Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
COVID-19
20200131
688232241000119100
Disease caused by Severe acute respiratory syndrome coronavirus 2 absent (situation)
Disease caused by Severe acute respiratory syndrome coronavirus 2 absent
20200731
840544004
Suspected disease caused by severe acute respiratory coronavirus 2 (situation)
Suspected COVID-19
20200131
Probably present (qualifier value)
Probably present
20040731
415684004
Suspected (qualifier value)
Suspected
20050131
Probably NOT present (qualifier value)
Probably NOT present
20040731
Acute hypoxemic respiratory failure due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Acute hypoxemic respiratory failure due to disease caused by Severe acute respiratory syndrome coronavirus 2
20200731
870589006
Acute kidney injury due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Acute kidney injury due to disease caused by Severe acute respiratory syndrome coronavirus 2
20200731
373895009
Acute respiratory distress (finding)
Acute respiratory distress
20020731
67782005
Acute respiratory distress syndrome (disorder)
Acute respiratory distress syndrome
20020131
674814021000119106
Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2
20200731
64779008
Blood coagulation disorder (disorder)
Blood coagulation disorder
20020731
119731000146105
Cardiomyopathy due to disease caused by Severe acute respiratory syndrome virus 2 (disorder)
Cardiomyopathy due to disease caused by Severe acute respiratory syndrome virus 2
20200731
62914000
Cerebrovascular disease (disorder)
Cerebrovascular disease
20020131
1119304009
Chronic post-COVID-19 syndrome (disorder)
Chronic post-COVID-19 syndrome
20210131
119741000146102
Conjunctivitis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Conjunctivitis due to disease caused by Severe acute respiratory syndrome coronavirus 2
20200731
710027002
Cytokine-associated toxicity (disorder)
Cytokine release syndrome
20150731
419099009
Dead (finding)
Dead
20060131
128053003
Deep venous thrombosis (disorder)
Deep venous thrombosis
20020131
34095006
Dehydration (disorder)
Dehydration
20020131
67406007
Disseminated intravascular coagulation (disorder)
Disseminated intravascular coagulation
20020131
3006004
Disturbance of consciousness (finding)
Disturbance of consciousness
20020131
119981000146107
Dyspnea caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Dyspnea caused by Severe acute respiratory syndrome coronavirus 2
20200731
1240561000000108
Encephalopathy due to disease caused by Severe acute respiratory syndrome virus 2 (disorder)
Encephalopathy due to disease caused by Severe acute respiratory syndrome virus 2
20200731
119751000146104
Fever caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Fever caused by Severe acute respiratory syndrome coronavirus 2
20200731
25374005
Gastroenteritis (disorder)
Gastroenteritis
20020131
56265001
Heart disease (disorder)
Heart disease
20020131
80394007
Hyperglycemia (disorder)
Hyperglycemia
20020131
389086002
Hypoxia (disorder)
Hypoxia
20030131
70944005
Impaired gas exchange (finding)
Impaired gas exchange
20080731
1240541000000107
Infection of upper respiratory tract caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Infection of upper respiratory tract caused by Severe acute respiratory syndrome coronavirus 2
20200731
90708001
Kidney disease (disorder)
Kidney disease
20020731
880529761000119102
Lower respiratory infection caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Lower respiratory infection caused by SARS-CoV-2
20200731
866151004
Lymphocytopenia due to Severe acute respiratory syndrome coronavirus 2 (disorder)
Lymphocytopenia due to Severe acute respiratory syndrome coronavirus 2
20200731
59455009
Metabolic acidosis (disorder)
Metabolic acidosis
20020131
57653000
Multiple organ failure (disorder)
Multiple organ failure
20020131
1240531000000103
Myocarditis due to disease caused by Severe acute respiratory syndrome virus 2 (disorder)
Myocarditis due to disease caused by Severe acute respiratory syndrome virus 2
20200731
1240521000000100
Otitis media due to disease caused by Severe acute respiratory syndrome virus 2 (disorder)
Otitis media due to disease caused by Severe acute respiratory syndrome virus 2
20200731
183676005
Died in hospital (finding)
Died in hospital
20020131
882784691000119100
Pneumonia caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Pneumonia caused by SARS-CoV-2
20200731
1119303003
Post-acute COVID-19 (disorder)
Post-acute COVID-19
20210131
870591003
Rhabdomyolysis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Rhabdomyolysis due to disease caused by Severe acute respiratory syndrome coronavirus 2
20200731
302846007
Rhabdomyoma (disorder)
Rhabdomyoma
20040731
308906005
Secondary bacterial pneumonia (disorder)
Secondary bacterial pneumonia
20160131
91302008
Sepsis (disorder)
Sepsis
20200131
870588003
Sepsis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Sepsis due to disease caused by Severe acute respiratory syndrome coronavirus 2
20200731
76571007
Septic shock (disorder)
Septic shock
20050131
415623008
Stress ulcer (disorder)
Stress ulcer
20050131
238149007
Systemic inflammatory response syndrome (disorder)
Systemic inflammatory response syndrome
20020131
866152006
Thrombocytopenia due to Severe acute respiratory syndrome coronavirus 2 (disorder)
Thrombocytopenia due to Severe acute respiratory syndrome coronavirus 2
20200731
429340002
Traumatic injury of skeletal muscle (disorder)
Traumatic injury of skeletal muscle
20080131
75570004
Viral pneumonia (disorder)
Viral pneumonia
20130731
1017214008
Viremia caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
SARS-CoV-2 viremia
20210131
Chronic disease (disorder)
Chronic disease
20020131
49601007
Disorder of cardiovascular system (disorder)
Disorder of cardiovascular system
20020131
414029004
Disorder of immune function (disorder)
Disorder of immune function
20190131
235856003
Disorder of liver (disorder)
Disorder of liver
20020131
118940003
Disorder of nervous system (disorder)
Disorder of nervous system
20020131
50043002
Disorder of respiratory system (disorder)
Disorder of respiratory system
20020131
722499006
Electronic cigarette user (finding)
Electronic cigarette user
20170131
8517006
Ex-smoker (finding)
Ex-smoker
20020131
80141007
Hemoglobinopathy (disorder)
Hemoglobinopathy
20020131
107921000119107
History of immune disorder (situation)
History of immune disorder
20150731
90708001
Kidney disease (disorder)
Kidney disease
20020731
363346000
Malignant neoplastic disease (disorder)
Malignant neoplastic disease
20020131
75934005
Metabolic disease (disorder)
Metabolic disease
20020131
414825006
Neoplasm of hematopoietic cell type (disorder)
Neoplasm of hematopoietic cell type
20050131
414915002
Obese (finding)
Obese
20050131
370388006
Patient immunocompromised (finding)
Patient immunocompromised
20020731
370391006
Patient immunosuppressed (finding)
Patient immunosuppressed
20020731
77386006
Pregnant (finding)
Pregnant
20020131
77176002
Smoker (finding)
Smoker
20020131
Corticosteroid and corticosteroid derivative therapy (procedure)
Corticosteroid and corticosteroid derivative therapy
20200131
234336002
Hemopoietic stem cell transplant (procedure)
Hemopoietic stem cell transplant
20050131
86553008
Immunosuppressive therapy (procedure)
Immunosuppressive therapy
20020131
76334006
Immunotherapy (procedure)
Immunological therapy
20020131
108290001
Radiation oncology AND/OR radiotherapy (procedure)
Radiation oncology AND/OR radiotherapy
20020131
312235007
Radiolabeled antibody therapy (procedure)
Radiolabeled antibody therapy
20020131
265764009
Renal dialysis (procedure)
Renal dialysis
20020131
313039003
Solid organ transplant (procedure)
Solid organ transplant
20060731
Occupational exposure to Severe acute respiratory syndrome coronavirus 2 (event)
Occupational exposure to SARS-CoV-2
20210131
21522001
Abdominal pain (finding)
Abdominal pain
20050131
84387000
Asymptomatic (finding)
Asymptomatic
20020131
84387000
Asymptomatic (finding)
Asymptomatic
20020131
255604002
Mild (qualifier value)
Mild
20020131
413384008
Ability to perform cognitive activity (observable entity)
Ability to perform cognitive activity
20050131
442476006
Arterial oxygen saturation (observable entity)
Arterial oxygen saturation
20090731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
288848001
Able to breathe (finding)
Able to breathe
20080731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
1119302008
Acute disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Acute COVID-19
20210131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
410605003
Confirmed present (qualifier value)
Confirmed present
20040731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
410594000
Definitely NOT present (qualifier value)
Definitely NOT present
20040731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
In GPS
292508471000119105
History of disease caused by severe acute respiratory syndrome coronavirus 2 (situation)
History of SARS-CoV-2
20200731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
138389411000119105
Acute bronchitis caused by severe acute respiratory syndrome coronavirus 2 (disorder)
Acute bronchitis caused by SARS-CoV-2
20200731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
78648007
At risk for infection (finding)
At risk for infection
20020131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
367336001
Chemotherapy (procedure)
Chemotherapy
20020131
CV19-ASS-Comorbidities
Intensional Definition:
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
840546002
Exposure to severe acute respiratory syndrome coronavirus 2 (event)
Exposure to SARS-CoV-2
20200131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
870577009
At increased risk of exposure to severe acute respiratory syndrome coronavirus 2 (finding)
At increased risk of exposure to severe acute respiratory syndrome coronavirus 2
20200731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
840533007
Severe acute respiratory syndrome coronavirus 2 (organism)
SARS-CoV-2
20200131
CV19-ASS-ViralCoInfections
Intensional Definition:
<< 49872002 |Virus (organism)| MINUS 840533007 |Severe acute respiratory syndrome coronavirus 2 (organism)|

131148009
6736007
386725007
77427003
189486241000119100
410592001
410593006
-
870590002
27624003
788751009
897036007